Astrocyte‐Specific Nrf2 Expression Transforms Neurotoxic Reactive Astrocytes to Neuroprotective Phenotype in 3xTg ‐ AD Mice
Glia · 2026
DOI: 10.1002/glia.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2026. Verfasst von Shenrui Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Astrocytes, Alzheimer Disease, Neuroprotection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Astrocyte reactivity is a common feature of Alzheimer's disease (AD), with reactive astrocytes traditionally subdivided into neurotoxic or neuroprotective phenotypes. It's crucial to transform neurotoxic reactive astrocytes to neuroprotective phenotypes for the treatment of AD, particularly during the progression of the disease. In this study, we evaluated the role of nuclear factor E2‐related factor 2 (Nrf2) in facilitating the phenotype transformation of reactive astrocytes in vivo and in vitro by overexpressing Nrf2 in hippocampal astrocytes of 3xTg‐AD mice using adeno‐associated virus (AAV) vectors, as well as treating neurotoxic reactive astrocytes with dimethyl fumarate (a Nrf2 activator). We also evaluated the therapeutic effect of astrocyte‐specific Nrf2 in 3xTg‐AD mice with coexpression of Aβ and tau pathologies. Our findings indicate that Nrf2 could facilitate the conversion of neurotoxic reactive astrocytes to neuroprotective phenotypes in vivo and in vitro. AAV‐mediated astrocyte‐specific Nrf2 expression improved cognitive function, reduced Aβ and tau pathologies, rescued the loss of neurons and synapses, and ameliorated neuroinflammation in 3xTg‐AD mice. These findings highlighted the role of Nrf2 in modulating reactive astrocyte phenotypes and suggested the potential for utilizing AAV to target astrocyte‐specific Nrf2 as a promising therapeutic strategy for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Chenglai Fu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Guo, S., Wei, F., Sun, H., Jin, H., Cheng, W., Fu, C., Wang, H., & Yin, Y. (2026). Astrocyte‐Specific Nrf2 Expression Transforms Neurotoxic Reactive Astrocytes to Neuroprotective Phenotype in 3xTg ‐ AD Mice. Glia. https://doi.org/10.1002/glia.70087
Vancouver
Guo S, Wei F, Sun H, Jin H, Cheng W, Fu C, et al. Astrocyte‐Specific Nrf2 Expression Transforms Neurotoxic Reactive Astrocytes to Neuroprotective Phenotype in 3xTg ‐ AD Mice. Glia. 2026. doi:10.1002/glia.70087
BibTeX
@article{Guo2026,
author = {Guo, Shenrui and Wei, Feng and Sun, Hui and Jin, Hongfu and Cheng, Weiwei and Fu, Chenglai and Wang, Hui and Yin, Yafu},
title = {Astrocyte‐Specific Nrf2 Expression Transforms Neurotoxic Reactive Astrocytes to Neuroprotective Phenotype in 3xTg ‐ AD Mice},
journal = {Glia},
year = {2026},
doi = {10.1002/glia.70087}
}
EUVIMED